In addition, CAF-derived IL-6 enhances the metastatic potential of lung cancer cells by activation of the JAK2/STAT3 signaling pathway [50,51], which in turn also mediates tumor angiogenesis through the upregulation of VEGF and bFGF [52]. The gene discussed is IL6; the disease is neoplasm.